DK3630188T3 - Farmaceutisk sammensætning omfattende en kombination af methotrexat og novobiocin og anvendelse af sammensætningen til behandling - Google Patents
Farmaceutisk sammensætning omfattende en kombination af methotrexat og novobiocin og anvendelse af sammensætningen til behandling Download PDFInfo
- Publication number
- DK3630188T3 DK3630188T3 DK18728619.0T DK18728619T DK3630188T3 DK 3630188 T3 DK3630188 T3 DK 3630188T3 DK 18728619 T DK18728619 T DK 18728619T DK 3630188 T3 DK3630188 T3 DK 3630188T3
- Authority
- DK
- Denmark
- Prior art keywords
- novobiocin
- methotrexate
- treatment
- combination
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1750688 | 2017-05-31 | ||
PCT/EP2018/064322 WO2018220101A1 (en) | 2017-05-31 | 2018-05-31 | A pharmaceutical composition comprising a combination of methotrexate and novobiocin, and the use of said composition in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3630188T3 true DK3630188T3 (da) | 2021-11-15 |
Family
ID=62492644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18728619.0T DK3630188T3 (da) | 2017-05-31 | 2018-05-31 | Farmaceutisk sammensætning omfattende en kombination af methotrexat og novobiocin og anvendelse af sammensætningen til behandling |
Country Status (6)
Country | Link |
---|---|
US (1) | US11883405B2 (da) |
EP (1) | EP3630188B1 (da) |
DK (1) | DK3630188T3 (da) |
ES (1) | ES2897200T3 (da) |
PL (1) | PL3630188T3 (da) |
WO (1) | WO2018220101A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675177A (zh) * | 2020-12-28 | 2021-04-20 | 南方医科大学珠江医院 | 包含抑制剂和甲氨蝶呤的药物组合物及其制备方法与应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
AU719434B2 (en) | 1996-02-13 | 2000-05-11 | Astrazeneca Ab | Quinazoline derivatives as VEGF inhibitors |
NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
BR9911621A (pt) | 1998-07-06 | 2001-10-16 | Bristol Myers Squibb Co | Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
JP2003520785A (ja) | 1999-12-15 | 2003-07-08 | ブリストル−マイヤーズ スクイブ カンパニー | アンジオテンシン・エンドセリン受容体二重拮抗薬としてのビフェニルスルホンアミド類 |
EP1261337B1 (en) | 2000-02-28 | 2008-09-10 | The University Of British Columbia | Topoisomerase inhibitors for treatment of surgical adhesions |
IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
CA2411160A1 (en) | 2000-07-07 | 2002-01-17 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
KR20030022264A (ko) | 2000-07-07 | 2003-03-15 | 앤지오젠 파마슈티칼스 리미티드 | 신생 혈관 형성 억제제인 콜치놀 유도체 |
US20080268045A1 (en) * | 2006-11-09 | 2008-10-30 | Proprius Pharmaceuticals, Inc. | Sustained release methotrexate formulations and methods of use thereof |
US10045937B2 (en) * | 2009-06-03 | 2018-08-14 | Case Western Reserve University | Therapeutic agent delivery system and method |
-
2018
- 2018-05-31 WO PCT/EP2018/064322 patent/WO2018220101A1/en active Application Filing
- 2018-05-31 DK DK18728619.0T patent/DK3630188T3/da active
- 2018-05-31 US US16/617,763 patent/US11883405B2/en active Active
- 2018-05-31 EP EP18728619.0A patent/EP3630188B1/en active Active
- 2018-05-31 ES ES18728619T patent/ES2897200T3/es active Active
- 2018-05-31 PL PL18728619T patent/PL3630188T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
EP3630188B1 (en) | 2021-08-25 |
US20200101074A1 (en) | 2020-04-02 |
US11883405B2 (en) | 2024-01-30 |
WO2018220101A1 (en) | 2018-12-06 |
EP3630188A1 (en) | 2020-04-08 |
ES2897200T3 (es) | 2022-02-28 |
PL3630188T3 (pl) | 2022-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
DK3468532T3 (da) | Dispenseranordning og farmaceutisk sammensætning til behandling af rhinitis | |
DK3487505T3 (da) | Indgivelse og dosering af diaminophenothiaziner | |
DK3303339T3 (da) | Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme | |
DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
EP3505161A4 (en) | SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+) - 2-BORNEOL | |
DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
EP3675860A4 (en) | SUBSTITUTED PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS AND ASSOCIATED THERAPEUTIC METHODS | |
EP3785698A4 (en) | Edaravone pharmaceutical composition | |
EP3552612A4 (en) | PHARMACEUTICAL PREPARATION AND MEDICAL INSTRUMENT | |
EP3689857A4 (en) | Griseofulvin compound and pharmaceutical use thereof | |
EP3615502A4 (en) | THERAPEUTIC COMPOUNDS AND PROCESSES | |
EP3583943A4 (en) | PHARMACEUTICAL COMPOSITION | |
DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
EP3737676A4 (en) | ACETAL COMPOUNDS AND THEIR THERAPEUTIC USES | |
DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
DK3275453T3 (da) | Farmaceutisk sammensætning med silibinin og ve | |
PL3443987T3 (pl) | Kompozycja farmaceutyczna do zapobiegania otyłości wywołanej dietą | |
DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi |